Highest Price Target1
Lowest Price Target1
Consensus Price Target1
Analyst Rating Summary1
Analyst Firms Making Recommendations1
- HC Wainwright & Co.
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Addex Therapeutics
What is the target price for Addex Therapeutics (ADXN)?
The latest price target for Addex Therapeutics (NASDAQ: ADXN) was reported by HC Wainwright & Co. on June 23, 2022. The analyst firm set a price target for $0.00 expecting ADXN to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Addex Therapeutics (ADXN)?
The latest analyst rating for Addex Therapeutics (NASDAQ: ADXN) was provided by HC Wainwright & Co., and Addex Therapeutics downgraded their neutral rating.
When is the next analyst rating going to be posted or updated for Addex Therapeutics (ADXN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Addex Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Addex Therapeutics was filed on June 23, 2022 so you should expect the next rating to be made available sometime around June 23, 2023.
Is the Analyst Rating Addex Therapeutics (ADXN) correct?
While ratings are subjective and will change, the latest Addex Therapeutics (ADXN) rating was a downgraded with a price target of $0.00 to $0.00. The current price Addex Therapeutics (ADXN) is trading at is $0.38, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.